UK markets closed

Xspray Pharma AB (publ) (XSPRAS.XC)

Cboe UK - Cboe UK Real-time price. Currency in SEK
Add to watchlist
0.00000.0000 (+0.20%)
At close: 08:04AM BST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
45,904
40,259
22,219
38,567
6,549
Selling general and administrative
158,949
133,115
80,424
58,384
47,101
Total operating expenses
213,778
180,765
131,382
96,951
53,645
Operating income or loss
-213,778
-180,765
-131,382
-96,951
-53,645
Interest expense
675
675
12
4
6
Income before tax
-212,638
-179,684
-131,670
-96,698
-52,410
Income tax expense
-57
-17
0
0
0
Income from continuing operations
-212,581
-179,667
-131,670
-96,698
-52,410
Net income
-212,581
-179,667
-131,670
-96,698
-52,410
Net income available to common shareholders
-212,581
-179,667
-131,670
-96,698
-52,410
Basic EPS
-7.60
-6.76
-6.25
-4.98
-3.02
Diluted EPS
-7.60
-6.76
-6.25
-4.98
-3.02
Basic average shares
24,140
26,594
21,071
19,413
17,368
Diluted average shares
24,140
26,594
21,071
19,413
17,841